文献速递胃肠外科围术期管理与 ERAS

吲哚菁绿荧光血管造影用于结直肠手术的成本效益分析:美国的多层面荟萃分析与成本分析

Analyzing costs versus savings using fluorescence angiography with indocyanine green for colorectal surgery in the United States: Multifaceted meta-analysis and cost analysis.
PubMed 文献 · Surgery · 2026-01-30

该研究通过荟萃分析与成本建模,比较美国结直肠手术中使用与不使用吲哚菁绿荧光血管造影的成本效益。综合自身及19项已发表荟萃分析显示吻合口漏率降低51.9%,5项随机对照试验荟萃分析显示至少降低36.5%。

要点

  • 吲哚菁绿荧光血管造影可降低结直肠手术吻合口漏率,证据等级为1级。
  • 每例患者平均直接医疗费用节省962至1138美元。

核心结论

  • 在结直肠手术吻合口评估中,使用吲哚菁绿荧光血管造影可降低美国每例患者直接医疗费用962至1138美元。
  • 减少再住院和再手术率可能带来额外节省。

研究设计与样本

  • 研究类型为荟萃分析与成本分析。
  • 检索PubMed/MEDLINE、EMBASE和Scopus,纳入所有评估吲哚菁绿荧光血管造影降低吻合口漏效果的荟萃分析和随机对照试验。
  • 自身荟萃分析仅纳入吲哚菁绿荧光血管造影组和对照组均≥100例患者的随机对照试验。
  • 使用2021-2023年Medicare Provider Analysis and Review账单数据识别直接医疗费用。
  • 构建最小、中间和最大成本分析模型,参数包括吻合口漏降低率、手术及并发症相关费用以及吲哚菁绿给药每单位成本225美元。

主要发现

  • 综合自身及19项已发表荟萃分析,吲哚菁绿荧光血管造影使吻合口漏率降低51.9%。
  • 5项限于随机对照试验的荟萃分析(包括自身研究)显示1级证据支持吻合口漏率至少降低36.5%。

关键数值与推荐

  • 最小和最大成本分析模型采用保守的吻合口漏降低率35%和50%。
  • 每例患者平均费用节省范围为962至1138美元。
  • 吲哚菁绿给药每单位成本设为225美元。

临床怎么用

  • 在结直肠手术中可考虑使用吲哚菁绿荧光血管造影进行吻合口评估,以降低吻合口漏风险并节省直接医疗费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indocyanine green fluorescence angiography is being increasingly used in colorectal surgery to reduce anastomotic leak risk, but few studies have analyzed its cost efficacy. In this study, cost modeling was used to compare costs in the United States using versus not using indocyanine green fluorescence angiography. METHODS: Exhaustive searches of PubMed/MEDLINE, EMBASE, and Scopus were used to identify all meta-analyses and randomized controlled trials assessing the effectiveness of indocyanine green fluorescence angiography in reducing anastomotic leaks. Additionally, we conducted our own meta-analysis restricted to randomized controlled trials with ≥100 patients in both indocyanine green fluorescence angiography and control groups. Three years (2021-2023) of Medicare Provider Analysis and Review billing data were then employed to identify direct health care costs. Minimum, intermediate, and maximum cost analysis models were created using indocyanine green fluorescence angiography-associated anastomotic leak reduction rates identified by synthesizing the results of meta-analyses and randomized controlled trials, procedural and complication-related costs identified via Medicare Provider Analysis and Review, and $225 as the per-unit cost of indocyanine green administration. RESULTS: Synthesis of the results of our own and 19 published meta-analyses revealed a 51.9% reduction in anastomotic leak rate with indocyanine green fluorescence angiography, whereas 5 meta-analyses restricted to randomized controlled trials, including our own, revealed level 1 evidence of at least a 36.5% reduction. Minimum and maximum cost analysis models were generated using conservative anastomotic leak reduction rates of 35% and 50%, from which mean per-patient cost reductions ranged from $962 to $1,138, and overall health care system savings ranged from $71 million to $84 million. CONCLUSION: For anastomotic assessments in colorectal surgery, indocyanine green fluorescence angiography reduces direct per-patient health care costs in the United States by $962 to $1,138. Additional savings may be derived from reduced rehospitalization and reoperation rates.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Goldhawk-White P, White K, Chand M, et al. Analyzing costs versus savings using fluorescence angiography with indocyanine green for colorectal surgery in the United States: Multifaceted meta-analysis and cost analysis. Surgery. 2026. PMID: 41619433. doi:10.1016/j.surg.2025.110072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。